- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10:01 | SIRNAOMICS-B (02257): VOLUNTARY ANNOUNCEMENT - BUSINESS UPDATE | 1 | HKEx | ||
| 08.12. | SIRNAOMICS-B (02257): VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING IN THE COMPANY BY A DIRECTOR | 1 | HKEx | ||
| 08.12. | SIRNAOMICS-B (02257): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| SIRNAOMICS Aktie jetzt für 0€ handeln | |||||
| 01.12. | SIRNAOMICS-B (02257): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | 1 | HKEx | ||
| 31.10. | SIRNAOMICS-B (02257): UPDATE ON IMPLEMENTATION OF REMEDIAL ACTIONS ON INTERNAL CONTROL WEAKNESSES AND DEFICIENCIES | 2 | HKEx | ||
| 22.10. | SIRNAOMICS-B (02257): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| 17.10. | SIRNAOMICS-B (02257): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | 1 | HKEx | ||
| 17.09. | SIRNAOMICS-B (02257): SUPPLEMENTAL ANNOUNCEMENT SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE | 1 | HKEx | ||
| 08.09. | SIRNAOMICS-B (02257): SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE | 2 | HKEx | ||
| 05.09. | SIRNAOMICS-B (02257): INTERIM REPORT 2025 | 2 | HKEx | ||
| 01.09. | SIRNAOMICS-B (02257): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | - | HKEx | ||
| 01.09. | SIRNAOMICS-B (02257): RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR, APPOINTMENT OF NON-EXECUTIVE DIRECTOR, INDEPENDENT NON-EXECUTIVE DIRECTOR, CHANGE ... | - | HKEx | ||
| 28.08. | SIRNAOMICS-B (02257): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025 | 1 | HKEx | ||
| 18.08. | SIRNAOMICS-B (02257): NOTICE OF BOARD MEETING | 2 | HKEx | ||
| 22.07. | SIRNAOMICS-B (02257): RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR | - | HKEx | ||
| 03.07. | SIRNAOMICS-B (02257): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | 2 | HKEx | ||
| 03.07. | SIRNAOMICS-B (02257): APPOINTMENT OF NON-EXECUTIVE DIRECTOR AND INDEPENDENT NON-EXECUTIVE DIRECTOR | 1 | HKEx |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CUREVAC | 3,396 | -4,82 % | BioNTech SE: BioNTech schließt Übernahme von CureVac N.V. samt damit verbundener Nachangebotsfrist ab und stärkt so die einzigartige Position im mRNA-Feld | BioNTech hat das Umtauschangebot zur Übernahme von CureVac abgeschlossenDie Übernahme von CureVac ergänzt BioNTechs Fähigkeiten und unternehmenseigene Technologien im Bereich mRNA-Design, Verabreichungsformulierungen... ► Artikel lesen | |
| QIAGEN | 39,120 | +1,76 % | QIAGEN N.V.: QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $500 Million | Return of approximately $500 million maximum approved by shareholders set to be completed on January 7, 2026 Capital return to be conducted through synthetic share repurchase combines a... ► Artikel lesen | |
| AVIDITY BIOSCIENCES | 72,11 | -0,30 % | Avidity Biosciences, Inc.: Avidity Biosciences Reports Third Quarter 2025 Financial Results and Recent Highlights | Announced Novartis agreement to acquire Avidity for total equity value of approximately $12 billion; Avidity expects to separate its early-stage precision cardiology... ► Artikel lesen | |
| COGENT BIOSCIENCES | 39,810 | +0,58 % | Cogent Biosciences, Inc.: Cogent Biosciences Announces Positive Top-line Results of APEX Trial of Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM) | -- Bezuclastinib demonstrated rapid and deep clinical benefit in AdvSM patients resulting in an objective response rate (CR+CRh+PR+CI) of 57% per mIWG criteria and 80% per PPR criteria -- -- Bezuclastinib... ► Artikel lesen | |
| BIONTECH | 79,05 | 0,00 % | Alarm bei Evotec! BioNTech und Vidac Pharma mit Erfolgen beim Kampf gegen Krebs! Analysten raten zum Kauf! | Bei Evotec läuten die Alarmglocken. Ein Großaktionär ist komplett beim deutschen Biotech-Unternehmen ausgestiegen. Dabei notiert das Wertpapier auf dem Niveau von 2016. Einen Meilenstein hat dagegen... ► Artikel lesen | |
| JYONG BIOTECH | 6,290 | +98,11 % | Jyong Biotech Ltd.: Jyong Biotech Responds to Share Price and Volume Movement | New Taipei City, Taiwan, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech") notes the recent fluctuation in its share price and the increased trading... ► Artikel lesen | |
| RECURSION PHARMACEUTICALS | 4,505 | +5,63 % | Cathie Wood's ARK sells Tesla stock, buys Coinbase and Recursion Pharmaceuticals | ||
| EVOTEC | 5,226 | +1,59 % | Eilmeldung am Abend: EVOTEC SE - jetzt wird's brisant! | ||
| IMMUNOME | 22,040 | +2,99 % | Immunome-Aktie fällt nach Ankündigung einer Kapitalerhöhung über 400 Mio. US-Dollar | ||
| OLEMA PHARMACEUTICALS | 28,550 | +2,59 % | From Olema To Insmed: Are These High-Flying Biotechs Still Worth Buying? | LONDON (dpa-AFX) - The biotech sector continues to deliver headline-grabbing moves, with stocks surging to fresh highs and companies advancing pivotal trials, regulatory filings, and strategic... ► Artikel lesen | |
| STRUCTURE THERAPEUTICS | 64,30 | -0,99 % | Structure Therapeutics Inc.: Structure Therapeutics Announces Initiation of Phase 1 Clinical Study of Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity | SAN FRANCISCO, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for... ► Artikel lesen | |
| VERA THERAPEUTICS | 53,30 | +4,24 % | Vera Therapeutics stock price target raised to $66 by BofA Securities | ||
| BEAM THERAPEUTICS | 28,130 | +5,87 % | BEACON Trial Data Makes Beam Therapeutics (BEAM) an Attractive Buy | ||
| SUMMIT THERAPEUTICS | 18,015 | +1,09 % | Summit Therapeutics stock rating reiterated by Cantor Fitzgerald | ||
| KYMERA THERAPEUTICS | 84,96 | +1,15 % | Kymera Therapeutics stock price target raised to $103 from $70 at RBC Capital |
SIRNAOMICS LTD gehört der Branche Biotechnologie an. Mit einer aktuellen Kursveränderung von -0,045 (-5,26 %) liegt der Kurs bei 0,810 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SIRNAOMICS LTD finden Sie auf Wallstreet Online.